83 related articles for article (PubMed ID: 1639860)
1. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism.
Waters CM; Overholser KA; Sorkin A; Carpenter G
J Cell Physiol; 1992 Aug; 152(2):253-63. PubMed ID: 1639860
[TBL] [Abstract][Full Text] [Related]
2. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
Starbuck C; Lauffenburger DA
Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.
Pim D; Collins M; Banks L
Oncogene; 1992 Jan; 7(1):27-32. PubMed ID: 1311063
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of epidermal growth factor endocytosis in rat hepatocytes. Effects of diabetes.
Dahmane A; Gil S; Bréhier A; Davy J; Féger J
Eur J Cell Biol; 1996 Apr; 69(4):335-42. PubMed ID: 8741215
[TBL] [Abstract][Full Text] [Related]
7. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.
Conrad M; Goldstein D; Andresson T; Schlegel R
Virology; 1994 May; 200(2):796-800. PubMed ID: 7909971
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression.
Sizemore N; Rorke EA
Cancer Res; 1993 Oct; 53(19):4511-7. PubMed ID: 8402622
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
10. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cell transformation by papillomavirus E5 proteins.
DiMaio D; Mattoon D
Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
[TBL] [Abstract][Full Text] [Related]
12. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
Rodríguez MI; Finbow ME; Alonso A
Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
[TBL] [Abstract][Full Text] [Related]
13. Characterization and identification of EGF-receptors as an integral component of membrane structure of human endometrial stromal cells in vitro.
Singer GA; Strowitzki T
Eur J Med Res; 1996 Jul; 1(10):484-90. PubMed ID: 9438146
[TBL] [Abstract][Full Text] [Related]
14. Subcellular structures involved in internalization and degradation of epidermal growth factor.
Fine RE; Goldenberg R; Sorrentino J; Herschman HR
J Supramol Struct Cell Biochem; 1981; 15(3):235-51. PubMed ID: 6267315
[TBL] [Abstract][Full Text] [Related]
15. Binding, internalization, and degradation of epidermal growth factor by balb 3T3 and BP3T3 cells: relationship to cell density and the stimulation of cell proliferation.
Brown KD; Yeh YC; Holley RW
J Cell Physiol; 1979 Aug; 100(2):227-38. PubMed ID: 315945
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
17. [125I]EGF binding ability is stable throughout the replicative life-span of WI-38 cells.
Phillips PD; Kuhnle E; Cristofalo VJ
J Cell Physiol; 1983 Mar; 114(3):311-6. PubMed ID: 6300148
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
[TBL] [Abstract][Full Text] [Related]
19. Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.
Korc M; Chandrasekar B; Shah GN
Cancer Res; 1991 Dec; 51(23 Pt 1):6243-9. PubMed ID: 1933884
[TBL] [Abstract][Full Text] [Related]
20. Regulation of thyroidal inducibility of Na,K-ATPase and binding of epidermal growth factor in wild-type and cold-sensitive E1a mutant type 5 adenovirus-transformed CREF cells.
Guernsey DL; Duigou GJ; Babiss LE; Fisher PB
J Cell Physiol; 1987 Dec; 133(3):507-14. PubMed ID: 2826499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
